Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

1(17%)

Results Posted

25%(1 trials)

Phase Distribution

Ph phase_2

50%

Ph phase_1

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

3(50.0%)

Phase 2Efficacy & side effects

3(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Terminated(1)

Detailed Status

Completed4

Withdrawn1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 13 (50.0%)

Phase 23 (50.0%)

Trials by Status

completed467%

withdrawn117%

active_not_recruiting117%

Recent Activity

1 active trials

Showing 5 of 6

active_not_recruitingphase_2

Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer

NCT03471650

completedphase_1

Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET

NCT03542773

withdrawnphase_2

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

NCT03800784

completedphase_1

Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer

NCT03793543

completedphase_2

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

NCT02981368

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT03471650Phase 2

Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer

Active Not Recruiting

NCT03542773Phase 1

Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET

Completed

NCT03800784Phase 2

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Withdrawn

NCT03793543Phase 1

Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer

Completed

NCT02981368Phase 2

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Completed

NCT03497377Phase 1

Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer.

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6